APA (7th ed.) Citation

N, M., S, M., L, D., E, N., L, G., G, K., . . . T, S. (2023). Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor-associated neurotoxicity. Cancer medicine, 12(8), 9373. https://doi.org/10.1002/cam4.5695

Chicago Style (17th ed.) Citation

N, Möhn, et al. "Monocyte Chemoattractant Protein 1 as a Potential Biomarker for Immune Checkpoint Inhibitor-associated Neurotoxicity." Cancer Medicine 12, no. 8 (2023): 9373. https://doi.org/10.1002/cam4.5695.

MLA (9th ed.) Citation

N, Möhn, et al. "Monocyte Chemoattractant Protein 1 as a Potential Biomarker for Immune Checkpoint Inhibitor-associated Neurotoxicity." Cancer Medicine, vol. 12, no. 8, 2023, p. 9373, https://doi.org/10.1002/cam4.5695.